How Advanced are Self-Assembled Nanomaterials for Targeted Drug Delivery?
The development of effective drug delivery systems is a key focus in pharmaceutical research, aiming to enhance therapeutic efficacy while
Tag: liposome
Repurposing chlorpromazine for anti-leukaemic therapy with the drug-in-cyclodextrin-in-liposome nanocarrier platform
Acute myeloid leukaemia (AML), accounts for 30 % of adult leukaemia cases, predominantly affects individuals over 60. The standard “7 + 3” intensive
Recent Advancements and Trends of Topical Drug Delivery Systems in Psoriasis: A Review and Bibliometric Analysis
Psoriasis is an immune-mediated inflammatory skin disease where topical therapy is crucial. While various dosage forms have enhanced the efficacy
Cyclodextrins permeabilize DPPC liposome membranes: a focus on cholesterol content, cyclodextrin type, and concentration
Cyclodextrins (CDs) are known for their ability to extract lipid components from synthetic and biological membranes and therefore to induce
Cyclodextrin-Coordinated Liposome-in-Gel for Transcutaneous Quercetin Delivery for Psoriasis Treatment
Psoriasis is a chronic inflammatory skin disease that is difficult to treat. Quercetin (QT) is a dietary flavonoid known for
BioNTech’s new invention: CD as potential cryoprotectant in lipid-based RNA formulation
BioNTech SE has recently (09.09.2022) filed a PCT patent application (WO2023036960, inventors: Hossam Hefesha, Heinrich Haas, Ferdia Bates, Christian Hotz
Multifunctional co-transport carriers based on cyclodextrin assembly for cancer synergistic therapy
In the past few years, drug delivery systems have been used extensively to improve solubility, stability, and pharmacokinetics of chemotherapeutic
Drug in CD in liposome for targeted delivery of anti-tubercular drugs
Nkanga and Krause have published in Nature Scientific Reports their recent development of a novel anti-tubercular drug delivery system. Isoniazid-hydrazone-phthalocyanine